Thyroid Nodules in Hispanic Americans: Baseline Demographic, Clinical, Radiological, and Pathological Characteristics in an Ongoing Registry
AACE Endocrinology and Diabetes · 2026-09
DOI: 10.1016/j.aed.2026.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-09. Verfasst von Rowena D’Souza und 10 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New York State Department of Health.
Abstract (Originalsprache)
Introduction
The primary goal of thyroid nodule evaluation is detecting malignancy. Due to the low prevalence and typically indolent nature of thyroid cancer, American Thyroid Association (ATA) guidelines emphasize reducing overdiagnosis and avoiding unnecessary surgery. Some studies suggest that cancer outcomes in Hispanic Americans are worse than in non-Hispanic Americans, raising concerns regarding whether current thyroid nodule evaluation guidelines are appropriate across ethnic groups.
Objective
To characterize the demographic, clinical, radiological, and pathological features of thyroid nodules in Hispanic Americans and compare findings with published general population data to assess whether intensified diagnostic evaluation is warranted Methods We created an ongoing, prospective registry of Hispanic Americans aged ≥18 years with diagnosed thyroid nodules. From January 2023 to January 2025, 211 subjects were enrolled. Cosmetic and ThyPRO-39 scores were calculated. Statistical analyses included descriptive statistics, unadjusted linear and ordinal regression, and the Kruskal-Wallis and Fisher Exact tests (p < 0.01). The registry is continuously updated.
Results
Among 211 subjects, median age was 59 years, and median BMI was 29 kg/m 2 . Most were female (92.4%) and referred for incidental imaging findings (73.0%), with only 1.0% reporting symptoms. FNA was performed in 102 subjects (48.3%), yielding Bethesda Categories II (69.6%), III (21.6%), I (5.9%), IV (2.0%), and V (1.0%). There were no Category VI results. Among 22 Category III nodules, 4 had molecular results suggesting high risk for malignancy. Pathology confirmed one follicular variant papillary thyroid carcinoma, one Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features, one oncocytic adenoma, and one papillary thyroid carcinoma. Thus, thyroid cancer was diagnosed in 2 of 211 subjects (0.9%).
Conclusion
The overall malignancy rate in this Hispanic American cohort was 0.9%, which is lower than the malignancy prevalence commonly reported in the general thyroid nodule population. When restricted to subjects undergoing fine-needle aspiration, the malignancy rate was 2.0%, more comparable to biopsy-selected cohorts. These findings support the continued use of current thyroid nodule evaluation and management guidelines in this population, without the need for more intensive screening approaches.
Förderung
- New York State Department of Health
Zitieren
APA
D’Souza, R., Lee, J., Sutanto, E., Liao, E., Sanchez, A., Ziskovich, K., Leung, T., Stojchevski, R., Kuriloff, D., Poretsky, L., & Sanchez, J. (2026). Thyroid Nodules in Hispanic Americans: Baseline Demographic, Clinical, Radiological, and Pathological Characteristics in an Ongoing Registry. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.014
Vancouver
D’Souza R, Lee J, Sutanto E, Liao E, Sanchez A, Ziskovich K, et al. Thyroid Nodules in Hispanic Americans: Baseline Demographic, Clinical, Radiological, and Pathological Characteristics in an Ongoing Registry. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.014
BibTeX
@article{DSouza2026,
author = {D’Souza, Rowena and Lee, Jee and Sutanto, Edward and Liao, Emilia and Sanchez, Angelica and Ziskovich, Karina and Leung, TungMing and Stojchevski, Radoslav and Kuriloff, Daniel and Poretsky, Leonid and Sanchez, Jose},
title = {Thyroid Nodules in Hispanic Americans: Baseline Demographic, Clinical, Radiological, and Pathological Characteristics in an Ongoing Registry},
journal = {AACE Endocrinology and Diabetes},
year = {2026},
doi = {10.1016/j.aed.2026.08.014}
}
EUVIMED